Stablepharma Receives MHRA Approval for Phase 1 Trial of Fridge-Free Tetanus & Diphtheria (Td) Vaccine

Dr Kenny Simmen named Chief Business Officer of Stablepharma Ltd

Stablepharma Secures €2.5m EIC Grant, recognised Among Europe’s Top 71 Innovators

Stablepharma named a Fierce Innovation Awards Winner!

Stablepharma & AJ Vaccines sign strategic LoI to distribute and commercialise Fridge-free Vaccines

Stablepharma nominated Finalist in Pharma Industry Awards UK 2024 – The Times

Dr. Steven Chatfield appointed as Non-Executive Chairman of Stablepharma Ltd

Dr. Bruce Roser retires from Stablepharma Ltd, leaving his legacy of thermostable vaccines

Stablepharma selected to be part of Innovate UK’s Scaleup Programme

Stablepharma achieve significant milestone in the GMP manufacture of a fridge-free Td vaccine

Stablepharma’s R&D Team in Madrid continues to expand

12 month stability data revealed for second fridge-free vaccine